Yasin Keshvargar discusses biotech IPOs with Law360
June 17, 2026
June 17, 2026
NEW YORK, June 17 [Category: BizLaw/Legal] -- Davis Polk and Wardwell, a law firm, posted the following news:
* * *
Yasin Keshvargar discusses biotech IPOs with Law360
*
Davis Polk partner Yasin Keshvargar discussed the uptick in biotech IPOs this year and the market outlook for the rest of 2026 with Law360.
"The pipeline is really robust. There are more biotech companies looking to go public now. The activity in the sector i . . .
* * *
Yasin Keshvargar discusses biotech IPOs with Law360
*
Davis Polk partner Yasin Keshvargar discussed the uptick in biotech IPOs this year and the market outlook for the rest of 2026 with Law360.
"The pipeline is really robust. There are more biotech companies looking to go public now. The activity in the sector i . . .
